A Novel Chemical Compound for Inhibition of SARS Coronavirus Helicase.
Identifieur interne : 000E83 ( Main/Exploration ); précédent : 000E82; suivant : 000E84A Novel Chemical Compound for Inhibition of SARS Coronavirus Helicase.
Auteurs : Jin-Moo Lee [Corée du Sud] ; Jin-Beom Cho [Corée du Sud] ; Hee-Chul Ahn [Corée du Sud] ; Woong Jung [Corée du Sud] ; Yong-Joo Jeong [Corée du Sud]Source :
- Journal of microbiology and biotechnology [ 1738-8872 ] ; 2017.
Descripteurs français
- KwdFr :
- ADN (antagonistes et inhibiteurs), Adénosine triphosphate, Antienzymes (), Antienzymes (isolement et purification), Antienzymes (pharmacologie), Antiviraux (), Antiviraux (antagonistes et inhibiteurs), Antiviraux (isolement et purification), Concentration inhibitrice 50, Helicase (), Humains, Hydrolyse, Lignée cellulaire (), Survie cellulaire (), Virus du SRAS (), Virus du SRAS (enzymologie).
- MESH :
- antagonistes et inhibiteurs : ADN, Antiviraux.
- enzymologie : Virus du SRAS.
- isolement et purification : Antienzymes, Antiviraux.
- pharmacologie : Antienzymes.
- Adénosine triphosphate, Antienzymes, Antiviraux, Concentration inhibitrice 50, Helicase, Humains, Hydrolyse, Lignée cellulaire, Survie cellulaire, Virus du SRAS.
English descriptors
- KwdEn :
- Adenosine Triphosphate, Antiviral Agents (antagonists & inhibitors), Antiviral Agents (chemistry), Antiviral Agents (isolation & purification), Cell Line (drug effects), Cell Survival (drug effects), DNA (antagonists & inhibitors), DNA Helicases (drug effects), Enzyme Inhibitors (chemistry), Enzyme Inhibitors (isolation & purification), Enzyme Inhibitors (pharmacology), Humans, Hydrolysis, Inhibitory Concentration 50, SARS Virus (drug effects), SARS Virus (enzymology).
- MESH :
- chemical , antagonists & inhibitors : Antiviral Agents, DNA.
- chemical , chemistry : Antiviral Agents, Enzyme Inhibitors.
- chemical , drug effects : DNA Helicases.
- chemical , isolation & purification : Antiviral Agents, Enzyme Inhibitors.
- chemical , pharmacology : Enzyme Inhibitors.
- chemical : Adenosine Triphosphate.
- drug effects : Cell Line, Cell Survival, SARS Virus.
- enzymology : SARS Virus.
- Humans, Hydrolysis, Inhibitory Concentration 50.
Abstract
We have discovered a novel chemical compound, (E)-3-(furan-2-yl)-N-(4-sulfamoylphenyl) acrylamide, that suppresses the enzymatic activities of SARS coronavirus helicase. To determine the inhibitory effect, ATP hydrolysis and double-stranded DNA unwinding assays were performed in the presence of various concentrations of the compound. Through these assays, we obtained IC50 values of 2.09 ± 0.30 µM (ATP hydrolysis) and 13.2 ± 0.9 µM (DNA unwinding), respectively. Moreover, we found that the compound did not have any significant cytotoxicity when 40 µM of it was used. Our results showed that the compound might be useful to be developed as an inhibitor against SARS coronavirus.
DOI: 10.4014/jmb.1707.07073
PubMed: 28910865
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000A78
- to stream PubMed, to step Curation: 000A78
- to stream PubMed, to step Checkpoint: 000B62
- to stream Ncbi, to step Merge: 002E49
- to stream Ncbi, to step Curation: 002E49
- to stream Ncbi, to step Checkpoint: 002E49
- to stream Main, to step Merge: 000E85
- to stream Main, to step Curation: 000E83
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A Novel Chemical Compound for Inhibition of SARS Coronavirus Helicase.</title><author><name sortKey="Lee, Jin Moo" sort="Lee, Jin Moo" uniqKey="Lee J" first="Jin-Moo" last="Lee">Jin-Moo Lee</name><affiliation wicri:level="1"><nlm:affiliation>Department of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Applied Chemistry, Kookmin University, Seoul 02707</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Cho, Jin Beom" sort="Cho, Jin Beom" uniqKey="Cho J" first="Jin-Beom" last="Cho">Jin-Beom Cho</name><affiliation wicri:level="1"><nlm:affiliation>Department of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Applied Chemistry, Kookmin University, Seoul 02707</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Ahn, Hee Chul" sort="Ahn, Hee Chul" uniqKey="Ahn H" first="Hee-Chul" last="Ahn">Hee-Chul Ahn</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, Dongguk University-Seoul, Gyeonggi-do 10326, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Pharmacy, Dongguk University-Seoul, Gyeonggi-do 10326</wicri:regionArea><wicri:noRegion>Gyeonggi-do 10326</wicri:noRegion></affiliation></author><author><name sortKey="Jung, Woong" sort="Jung, Woong" uniqKey="Jung W" first="Woong" last="Jung">Woong Jung</name><affiliation wicri:level="1"><nlm:affiliation>Department of Emergency Medicine, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Emergency Medicine, Kyung Hee University Hospital at Gangdong, Seoul 05278</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Jeong, Yong Joo" sort="Jeong, Yong Joo" uniqKey="Jeong Y" first="Yong-Joo" last="Jeong">Yong-Joo Jeong</name><affiliation wicri:level="1"><nlm:affiliation>Department of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Applied Chemistry, Kookmin University, Seoul 02707</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28910865</idno><idno type="pmid">28910865</idno><idno type="doi">10.4014/jmb.1707.07073</idno><idno type="wicri:Area/PubMed/Corpus">000A78</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A78</idno><idno type="wicri:Area/PubMed/Curation">000A78</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A78</idno><idno type="wicri:Area/PubMed/Checkpoint">000B62</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000B62</idno><idno type="wicri:Area/Ncbi/Merge">002E49</idno><idno type="wicri:Area/Ncbi/Curation">002E49</idno><idno type="wicri:Area/Ncbi/Checkpoint">002E49</idno><idno type="wicri:Area/Main/Merge">000E85</idno><idno type="wicri:Area/Main/Curation">000E83</idno><idno type="wicri:Area/Main/Exploration">000E83</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A Novel Chemical Compound for Inhibition of SARS Coronavirus Helicase.</title><author><name sortKey="Lee, Jin Moo" sort="Lee, Jin Moo" uniqKey="Lee J" first="Jin-Moo" last="Lee">Jin-Moo Lee</name><affiliation wicri:level="1"><nlm:affiliation>Department of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Applied Chemistry, Kookmin University, Seoul 02707</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Cho, Jin Beom" sort="Cho, Jin Beom" uniqKey="Cho J" first="Jin-Beom" last="Cho">Jin-Beom Cho</name><affiliation wicri:level="1"><nlm:affiliation>Department of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Applied Chemistry, Kookmin University, Seoul 02707</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Ahn, Hee Chul" sort="Ahn, Hee Chul" uniqKey="Ahn H" first="Hee-Chul" last="Ahn">Hee-Chul Ahn</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, Dongguk University-Seoul, Gyeonggi-do 10326, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Pharmacy, Dongguk University-Seoul, Gyeonggi-do 10326</wicri:regionArea><wicri:noRegion>Gyeonggi-do 10326</wicri:noRegion></affiliation></author><author><name sortKey="Jung, Woong" sort="Jung, Woong" uniqKey="Jung W" first="Woong" last="Jung">Woong Jung</name><affiliation wicri:level="1"><nlm:affiliation>Department of Emergency Medicine, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Emergency Medicine, Kyung Hee University Hospital at Gangdong, Seoul 05278</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Jeong, Yong Joo" sort="Jeong, Yong Joo" uniqKey="Jeong Y" first="Yong-Joo" last="Jeong">Yong-Joo Jeong</name><affiliation wicri:level="1"><nlm:affiliation>Department of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Applied Chemistry, Kookmin University, Seoul 02707</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author></analytic><series><title level="j">Journal of microbiology and biotechnology</title><idno type="eISSN">1738-8872</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine Triphosphate</term><term>Antiviral Agents (antagonists & inhibitors)</term><term>Antiviral Agents (chemistry)</term><term>Antiviral Agents (isolation & purification)</term><term>Cell Line (drug effects)</term><term>Cell Survival (drug effects)</term><term>DNA (antagonists & inhibitors)</term><term>DNA Helicases (drug effects)</term><term>Enzyme Inhibitors (chemistry)</term><term>Enzyme Inhibitors (isolation & purification)</term><term>Enzyme Inhibitors (pharmacology)</term><term>Humans</term><term>Hydrolysis</term><term>Inhibitory Concentration 50</term><term>SARS Virus (drug effects)</term><term>SARS Virus (enzymology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>ADN (antagonistes et inhibiteurs)</term><term>Adénosine triphosphate</term><term>Antienzymes ()</term><term>Antienzymes (isolement et purification)</term><term>Antienzymes (pharmacologie)</term><term>Antiviraux ()</term><term>Antiviraux (antagonistes et inhibiteurs)</term><term>Antiviraux (isolement et purification)</term><term>Concentration inhibitrice 50</term><term>Helicase ()</term><term>Humains</term><term>Hydrolyse</term><term>Lignée cellulaire ()</term><term>Survie cellulaire ()</term><term>Virus du SRAS ()</term><term>Virus du SRAS (enzymologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Antiviral Agents</term><term>DNA</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiviral Agents</term><term>Enzyme Inhibitors</term></keywords><keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>DNA Helicases</term></keywords><keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Antiviral Agents</term><term>Enzyme Inhibitors</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Enzyme Inhibitors</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Adenosine Triphosphate</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>ADN</term><term>Antiviraux</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cell Line</term><term>Cell Survival</term><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Antienzymes</term><term>Antiviraux</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antienzymes</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Hydrolysis</term><term>Inhibitory Concentration 50</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adénosine triphosphate</term><term>Antienzymes</term><term>Antiviraux</term><term>Concentration inhibitrice 50</term><term>Helicase</term><term>Humains</term><term>Hydrolyse</term><term>Lignée cellulaire</term><term>Survie cellulaire</term><term>Virus du SRAS</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We have discovered a novel chemical compound, (E)-3-(furan-2-yl)-<i>N</i>-(4-sulfamoylphenyl) acrylamide, that suppresses the enzymatic activities of SARS coronavirus helicase. To determine the inhibitory effect, ATP hydrolysis and double-stranded DNA unwinding assays were performed in the presence of various concentrations of the compound. Through these assays, we obtained IC<sub>50</sub> values of 2.09 ± 0.30 µM (ATP hydrolysis) and 13.2 ± 0.9 µM (DNA unwinding), respectively. Moreover, we found that the compound did not have any significant cytotoxicity when 40 µM of it was used. Our results showed that the compound might be useful to be developed as an inhibitor against SARS coronavirus.</div></front></TEI><affiliations><list><country><li>Corée du Sud</li></country><region><li>Région capitale de Séoul</li></region><settlement><li>Séoul</li></settlement></list><tree><country name="Corée du Sud"><region name="Région capitale de Séoul"><name sortKey="Lee, Jin Moo" sort="Lee, Jin Moo" uniqKey="Lee J" first="Jin-Moo" last="Lee">Jin-Moo Lee</name></region><name sortKey="Ahn, Hee Chul" sort="Ahn, Hee Chul" uniqKey="Ahn H" first="Hee-Chul" last="Ahn">Hee-Chul Ahn</name><name sortKey="Cho, Jin Beom" sort="Cho, Jin Beom" uniqKey="Cho J" first="Jin-Beom" last="Cho">Jin-Beom Cho</name><name sortKey="Jeong, Yong Joo" sort="Jeong, Yong Joo" uniqKey="Jeong Y" first="Yong-Joo" last="Jeong">Yong-Joo Jeong</name><name sortKey="Jung, Woong" sort="Jung, Woong" uniqKey="Jung W" first="Woong" last="Jung">Woong Jung</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E83 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000E83 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28910865
|texte= A Novel Chemical Compound for Inhibition of SARS Coronavirus Helicase.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28910865" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |